U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07084571) titled 'Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution' on July 02.
Brief Summary: FORTITUDE is a translational research study that aims to collect serial multi-site needle biopsy samples of tumour tissue and blood from metastatic breast cancer patients. Cancer biopsies are generally performed when cancer is diagnosed and are sometimes repeated when the cancer is suspected to have spread but this is not mandatory. However, studies have shown that cancers change with time and evolve to become resistant to therapy. The purpose of this study is to assess the feasibility of biopsies of multiple cancer sites...